FDA Inspection 1265748 — Apotex Research Private Limited

Apotex Research Private Limited — FEI 3007078919

The FDA completed an inspection of Apotex Research Private Limited on Dec 13, 2024 in Bangalore. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Dec 13, 2024
Fiscal Year
2025
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Bangalore (India)

Additional Details

Bioanalytical BA/BE

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.